| SEPTEMBER, 2014 Gene-Related Patents Issued - Full patent: http://patft.uspto.gov/netahtml/PTO/srchnum.htm | ||||
| CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,846,385 | Method and means for producing high titer, safe recombinant lentivirus vectors | Algenol Biofuels Inc. | 30-Sep-14 | United States |
| 8,835,153 | Process and genes for expression and overexpression of active [FeFe] hydrogenases | Alliance for Sustainable Energy, LLC | 16-Sep-14 | United States |
| 8,822,166 | Stimulus-elicited genomic profile markers of alzheimer's disease | Blanchette Rockefeller Neurosciences Institute | 2-Sep-14 | United States |
| 8,828,687 | Method for the production of recombinant virus, DNA constructs, recombinant virus and vaccine compositions | Bonaldo; Myrna Cristina | 9-Sep-14 | Brazil |
| 8,828,718 | Gene transfer vectors comprising genetic insulator elements and methods to identify genetic insulator elements | Centre National de la Recherche Scientifique | 9-Sep-14 | France |
| 8,835,105 | Sperm-specific cation channel, CatSper4, and uses therefor | Children's Medical Center Corporation | 16-Sep-14 | United States |
| 8,835,154 | Microorganism having enhanced L-amino acids productivity and process for producing L-amino acids using the same | CJ Cheiljedang Corporation | 16-Sep-14 | Korea |
| 8,846,367 | Coryneform bacterium transformant and process for producing phenol using the same | Danisco US Inc. | 30-Sep-14 | United States |
| 8,841,088 | Method for mRNA stabilization | DSM IP Assets B.V. | 23-Sep-14 | Netherlands |
| 8,822,185 | Peroxisome biogenesis factor protein (PEX) disruptions for altering polyunsaturated fatty acids and total lipid content in oleaginous eukaryotic organisms | E I du Pont de Nemours and Company | 2-Sep-14 | United States |
| 8,822,222 | Apparatus for generating electrical pulses and methods of using same | Eastern Virginia Medical School | 2-Sep-14 | United States |
| 8,835,106 | Method for typing and detecting HBV | Fujirebio Europe N.V. | 16-Sep-14 | Belogium |
| 8,846,387 | Targeted gene modification by parvoviral vectors | GBP IP, LLC | 30-Sep-14 | United States |
| 8,846,369 | Cyanobacterium sp. host cell and vector for production of chemical compounds in cyanobacterial cultures | Green Phenol Development Co., Ltd. | 30-Sep-14 | Japan |
| 8,828,662 | Method and kit for detection of microsatellite instability-positive cell | Hitachi, Ltd. | 9-Sep-14 | Japan |
| 8,828,686 | Polynucleotides encoding therapeutic inhibitors of PAI-1 | Intrexon Corporation | 9-Sep-14 | United States |
| 8,828,699 | Eukaryotic amadoriase, gene and recombinant DNA for the eukaryotic amadoriase, and process for production of the eukaryotic amadoriase | Kikkoman Corporation | 9-Sep-14 | Japan |
| 8,835,147 | Cellular production of glucaric acid through recombinant expression of uronate dehydrogenase and myo-inositol oxygenase | Massachusetts Institute of Technology | 16-Sep-14 | United States |
| 8,841,094 | Homologous recombination method, cloning method, and kit | National University Corporation University of Toyama | 23-Sep-14 | Japan |
| 8,846,318 | Method for identifying olfactory receptor included in one olfactory cell | Panasonic Corporation | 30-Sep-14 | Japan |
| 8,841,074 | MPL mutations in JAK2 V617F negative patients with myeloproliferative disease | Quest Diagnostics Investments Incorporated | 23-Sep-14 | United States |
| 8,846,402 | Method for genetically modifying isolated non-human mammalian cell by homologous recombination | Regeneron Pharmaceuticals, Inc. | 30-Sep-14 | United States |
| 8,822,180 | Method of synthesizing a suppressor tRNA, DNA construct and use thereof for producing a non-natural amino acid-incorporated protein | Riken | 2-Sep-14 | Japan |
| 8,846,364 | Method to improve the stability and broaden the pH range of family G/11 xylanases | Sharp Kabushiki Kaisha | 30-Sep-14 | Japan |
| 8,841,126 | Method for gene transfer | Takara Bio Inc. | 23-Sep-14 | Japan |
| 8,835,177 | Method for transfer of gene into fat cell or progenitor fat cell | Takara Bio Inc. | 16-Sep-14 | Japan |
| 8,822,155 | Quantitative multiplex methylation-specific PCR | The Johns Hopkins University | 2-Sep-14 | United States |
| 8,828,652 | Elimination of N-glycolylneuraminic acid from animal products for human use | The Regents of the University of California | 9-Sep-14 | United States |
| 8,822,216 | DNA regulatory element for the expression of transgenes in neurons of a subject and uses thereof | The Trustees of Columbia University in the City of New York | 2-Sep-14 | United States |
| 8,822,153 | Molecular diagnosis and typing of lung cancer variants | The University of North Carolina at Chapel Hill | 2-Sep-14 | United States |
| 8,846,396 | Methods for the isolation of cardiac stem cells | The University of Washington | 30-Sep-14 | United States |
| 8,828,693 | Method for producing isopropanol and recombinant yeast capable of producing isopropanol | Toyora Jidosha Kabushiki Kaisha | 9-Sep-14 | Japan |
| 8,846,398 | Method for preparing human neoplastically transformed cells | Universita Degli Studi Di Roma "La Sapienza" | 30-Sep-14 | Italy |
| 8,846,358 | Method and device for producing hydrogen | Yamaguchi University | 30-Sep-14 | Japan |
| 8,846,343 | High-expression promoter derived from Kluyveromyces marxianus | Yamaguchi University | 30-Sep-14 | Japan |
| 8,846,315 | Disease risk factors and methods of use | Zinfandel Pharmaceuticals, Inc. | 30-Sep-14 | United States |
| COMBINATORIAL CHEMISTRY TECHNOLOGY | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,846,578 | Zinc finger nuclease for the CFTR gene and methods of use thereof | The General Hospital Corporation | 30-Sep-14 | United States |
| 8,846,577 | Phage display using cotranslational translocation of fusion polypeptides | University of Zurich | 30-Sep-14 | Switzerland |
| DATA PROCESSING | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,849,576 | Phylogenetic analysis of mass spectrometry or gene array data for the diagnosis of physiological conditions | Amri; Hakima | 30-Sep-14 | United States |
| 8,843,320 | Use of gene expression profiling to predict survival in cancer patient | Board of Trustees of the University of Arkansas | 23-Sep-14 | United States |
| 8,831,890 | System and method for determining individualized medical intervention for a disease state | Caris MPI, Inc. | 9-Sep-14 | United States |
| 8,825,560 | Distributed evolutionary algorithm for asset management and trading | Genetic Finance (Barbados) Limited | 2-Sep-14 | Barbadose |
| 8,843,356 | Computer systems and methods for associating genes with traits using cross species data | Merck Sharp & Dohme Corp. | 23-Sep-14 | United States |
| 8,832,581 | Gene expression browser for web-based search and visualization of characteristics of gene expression | Zhang; Ming | 9-Sep-14 | United States |
| DRUG | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,828,964 | Cancer cell identification marker and cancer cell proliferation inhibitor | Accural Inc. | 9-Sep-14 | Japan |
| 8,846,043 | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer | Agensys, Inc. | 30-Sep-14 | United States |
| 8,821,869 | Treatment methods using c-Met antibodies | Amgen Fremont Inc. | 2-Sep-14 | United States |
| 8,828,456 | Method of external skin application of composition containing red pine root extract | Amorepacific Corporation | 9-Sep-14 | Korea |
| 8,828,934 | Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism | Boehringer Ingelheim International GmbH | 9-Sep-14 | Germany |
| 8,821,856 | Method of targeted gene delivery using viral vectors | California Institute of Technology | 2-Sep-14 | United States |
| 8,835,480 | Inhibitors for steroid response elements and related methods | California Institute of Technology | 16-Sep-14 | United States |
| 8,828,939 | Modified vitamin K dependent polypeptides | CSL Behring GmbH | 9-Sep-14 | Germany |
| 8,841,267 | Micro-RNA scaffolds, non-naturally occurring micro-RNAs, and methods for optimizing non-naturally occurring micro-RNAs | GE Healthcare Dharmacon, Inc. | 23-Sep-14 | United States |
| 8,828,959 | Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells | Gene Signal International SA | 9-Sep-14 | Switzerland |
| 8,821,892 | Yeast-based therapeutic for chronic hepatitis C infection | GlobeImmune, Inc. | 2-Sep-14 | United States |
| 8,828,406 | Influenza viruses and uses thereof | Icahn School of Medicine at Mount Sinai | 9-Sep-14 | United States |
| 8,821,862 | Soluble .beta.-N-acetylglucosaminidase based antibiofilm compositions and uses thereof | Kane Biotech Inc. | 2-Sep-14 | United States |
| 8,841,272 | Double-stranded RNA-based nanoparticles for insect gene silencing | Kansas State University Research Foundation | 23-Sep-14 | United States |
| 8,846,630 | Pharmaceutical composition for treating cancer | Korea Research Institute of Bioscience and Biotechnology | 30-Sep-14 | Korea |
| 8,846,625 | Glucagon-like peptide-2 analogs | NPS Pharmaceuticals, Inc. | 30-Sep-14 | United States |
| 8,828,356 | Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis | Progeria Research Foundation, Inc. | 9-Sep-14 | United States |
| 8,841,268 | Method and kit for detection of cancer, and therapeutic agent for cancer | Sapporo Medical University | 23-Sep-14 | Japan |
| 8,828,958 | Single-stranded antimicrobial oligonucleotides and uses thereof | Star Biologics, Inc. | 9-Sep-14 | United States |
| RE45,170 | Streptococcus suis vaccines and diagnostic tests | Stichting Dienst Landbouwkundig Onderzoek | 30-Sep-14 | Netherlands |
| 8,846,629 | Id-1 and Id-2 genes and products as therapeutic targets for treatment of breast cancer and other types of carcinoma | The Regents of the University of California | 30-Sep-14 | United States |
| 8,834,863 | Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof | The Trustees of the University of Pennsylvania | 16-Sep-14 | United States |
| 8,846,031 | Simian adenovirus 41 and uses thereof | The Trustees of the University of Pennsylvania | 30-Sep-14 | United States |
| 8,822,540 | Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation | The United States of America, as represented by the Secretary, Department of Health and Human Services | 2-Sep-14 | United States |
| 8,828,378 | Targeted vectors for cancer immunotherapy | The University of Southern California | 9-Sep-14 | United States |
| 8,828,954 | Use for scopolin and derivatives thereof | Yonsei University Technology Holdings, Inc. | 9-Sep-14 | Korea |
| ETCHING A SUBSTRATE: PROCESSES | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,828,246 | Method of fabricating micro-devices | Anpac Bio-Medical Science Co., Ltd. | 9-Sep-14 | British Virgin Islands |
| IMAGE ANALYSIS | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,848,988 | Appliance and method for evaluation and assessment of a test strip | Optricon GmbH | 30-Sep-14 | Germany |
| INFORMATION SECURITY | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,832,808 | Cyber gene identification technology based on entity features in cyber space | Liu; Nanjie | 9-Sep-14 | China P Rep |
| MULTICELLULAR LIVING ORGANISMS | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,829,272 | Specific expression using transcriptional control sequences in plants | Adelaide Research & Innovation Pty Ltd | 9-Sep-14 | Australia |
| 8,835,715 | Plants expressing .DELTA.6-desaturase genes and oils from these plants containing PUFAS and method for producing unsaturated fatty acids | BASF Plant Science GmbH | 16-Sep-14 | Germany |
| 8,847,018 | Plants tolerant to HPPD inhibitor herbicides | Bayer CropScience AG | 30-Sep-14 | Germany |
| 8,847,017 | Plants tolerant to HPPD inhibitor herbicides | Bayer CropScience AG | 30-Sep-14 | Germany |
| 8,829,264 | Methods and compositions for RNA interference | Cold Spring Harbor Laboratory | 9-Sep-14 | United States |
| 8,822,754 | Ecdysone receptor-based inducible gene expression system | Intrexon Corporation | 2-Sep-14 | United States |
| 8,829,275 | Methods and compositions for obtaining marker-free transgenic plants | Monsanto Technology LLC | 9-Sep-14 | United States |
| 8,841,508 | Non-human mammalian animal model for type 2 diabetes | National University Corporation | 23-Sep-14 | Japan |
| 8,829,315 | Wheat with altered branching enzyme activity and starch containing products derived therefrom | Commonwealth Scientific and Industrial Research Organisation | 9-Sep-14 | Australia |
| 8,822,758 | Gene capable of increasing the production of plant biomass and method for using the same | Toyota Jidosha Kabushiki Kaisha | 2-Sep-14 | Japan |
| NATURAL RESINS OR DERIVATIVES | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,822,646 | Cancer therapies and pharmaceutical compositions used therein | ProNAi Therapeutics, Inc. | 2-Sep-14 | United States |
| 8,841,423 | Monoclonal antibodies specific for oxidized calcium/calmodulin dependent protein kinase II | University of Iowa Research Foundation | 23-Sep-14 | United States |
| 8,835,618 | Mutations of the parkin gene | Aventis Pharma S.A. | 16-Sep-14 | France |
| 8,835,622 | Expression cassettes for seed-specific expression in plants | Bayer BioScience N.V. | 16-Sep-14 | Belgium |
| 8,846,884 | Method for enrichment and isolation of endogenous transcription factor and complexes thereof and corresponding tandem arrays of concatenated transcription factor response elements | Baylor College of Medicine | 30-Sep-14 | Germany |
| 8,835,621 | Synthetic 5'UTRs, expression vectors, and methods for increasing transgene expression | Intrexon Corporation | 16-Sep-14 | United States |
| 8,829,169 | Assay for imidazolinone resistance mutations in Brassica species | Monsanto Canada Inc. | 9-Sep-14 | Canada |
| 8,835,623 | RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) | Sirna Therapeutics, Inc | 16-Sep-14 | United States |
| 8,846,894 | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) | Sirna Therapeutics, Inc | 30-Sep-14 | United States |
| 8,841,432 | Shuttle vectors for mycobacteria-escherichia coli and uses thereof | SNU R&DB Foundation | 23-Sep-14 | Korea |
| 8,835,108 | RNA containing modified nucleosides and methods of use thereof | The Trustees of the University of Pennsylvania | 16-Sep-14 | United States |
| 8,846,889 | Peptide biosynthesis and pain therapy | Wolfe; Darren P. | 30-Sep-14 | United States |
| SYNTHETIC RESINS OR NATURAL RUBBERS | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,846,850 | Amphiphilic macromolecules for nucleic acid delivery | Rutgers, the State University of New Jersey | 30-Sep-14 | United States |
| 8,829,109 | Cleavable modifications to reducible poly(amido ethylenimine)s to enhance nucleotide delivery | University of Utah Research Foundation | 9-Sep-14 | United States |
Login
To traslate this page, click a flag!
